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Abstract Rift Valley fever phlebovirus (RVFV) is a clinically and economically important pathogen
increasingly likely to cause widespread epidemics. RVFV virulence depends on the interferon
antagonist non-structural protein (NSs), which remains poorly characterized. We identified a stable
core domain of RVFV NSs (residues 83–248), and solved its crystal structure, a novel all-helical fold
organized into highly ordered fibrils. A hallmark of RVFV pathology is NSs filament formation in
infected cell nuclei. Recombinant virus encoding the NSs core domain induced intranuclear
filaments, suggesting it contains all essential determinants for nuclear translocation and filament
formation. Mutations of key crystal fibril interface residues in viruses encoding full-length NSs
completely abrogated intranuclear filament formation in infected cells. We propose the fibrillar
arrangement of the NSs core domain in crystals reveals the molecular basis of assembly of this key
virulence factor in cell nuclei. Our findings have important implications for fundamental
understanding of RVFV virulence.
DOI: https://doi.org/10.7554/eLife.29236.001
Introduction
Rift Valley fever phlebovirus (RVFV), of the genus Phlebovirus, is one of the most clinically significant
members of the Phenuiviridae family, of the Bunyavirales order (Elliott and Brennan, 2014;
Plyusnin et al., 2012; Adams et al., 2017). RVFV is an arbovirus spread by many mosquito vector
species as well as by exposure to infected tissues. It causes recurring epidemics in livestock and
humans (Ikegami and Makino, 2011). The most prominent effect of RVFV infection in ruminants is a
high rate of abortions. In humans infections are usually self-limiting, but can develop into hepatitis,
retinitis, encephalitis and hemorrhagic fever with fatality rates of 0.5–2% (Pepin et al., 2010).
Although originally endemic to sub-Saharan Africa, RVFV has recently appeared in Madagascar, the
Comoros and the Arabian Peninsula (Balkhy and Memish, 2003). Increasing spread of competent
mosquito vector species due to climate change could facilitate emergence of this virus in new eco-
systems, including Europe and the United States (Chevalier, 2013; Elliott, 2009; Golnar et al.,
2014; Rolin et al., 2013). In 2017 the World Health Organization ranked RVFV among the ten most
dangerous pathogens most likely to cause wide epidemics in the near future, requiring urgent atten-
tion (http://www.who.int/blueprint/priority-diseases/en/). While an animal vaccine for RVFV exists,
there is no treatment available for human use (Boshra et al., 2011; Lihoradova and Ikegami, 2014).
RVFV is a zoonotic arbovirus evolved to evade the immune response of mammals and insects.
Innate immune antagonism of RVFV is primarily mediated by its main virulence factor, the 30 kDa
non-structural protein (NSs), which is transcribed and translated from a subgenomic mRNA derived
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from the antigenomic S segment early during infection. NSs impedes interferon production through
three known mechanisms (Billecocq et al., 2004; Bouloy et al., 2001). In infected host cells, NSs is
transported into the nucleus where it interferes with the assembly of the RNA polymerase II preinitia-
tion complex transcription factor II H (TFIIH) by binding to the p44 subunit (Le May et al., 2004) and
directing the p62 subunit for degradation (Kainulainen et al., 2014; Kalveram et al., 2011), thereby
halting global cellular transcription. NSs also prevents activation of the interferon-b promoter specifi-
cally by binding to factor SAP30, a member of a multisubunit histone deacetylase transcriptional
repression complex that regulates interferon-b expression (Le May et al., 2008). Furthermore, NSs
blocks host recognition of viral dsRNA by targeting the RNA-dependent protein kinase (PKR) for
degradation (Ikegami et al., 2009a, 2009b). RVFV with a deletion of NSs cannot establish viremia
and is not pathogenic in the mouse model (Bouloy et al., 2001).
A characteristic feature of RVFV pathogenesis is formation of 0.5 mm thick proteinaceous fila-
ments formed by bundles of thin fibrils in the nuclei of infected cells (Swanepoel and Blackburn,
1977). The filaments are composed primarily of NSs protein (Struthers and Swanepoel, 1982;
Yadani et al., 1999) but co-localize with p44, XPB, SAP30 and YY1, as well (Le May et al., 2004,
2008). It is not clear if filament formation is required for NSs function, that is if any interaction sites
are present on the monomeric form of the protein, or are only present in the multimerized, fibrillar
NSs. In the absence of structural information it is difficult to dissect NSs function from filament for-
mation. Potential functions of nuclear NSs filaments include sequestering NSs binding partners, caus-
ing cell cycle arrest and defects in chromosome cohesion and segregation (Mansuroglu et al.,
2010). This could contribute to the high rate of fetal deformities and abortions observed in RVFV-
infected ruminants (Baer et al., 2012; Mansuroglu et al., 2010).
NSs proteins are encoded in the S segment of the tripartite negative sense single strand RNA
genome of most members of the Phlebovirus genus, and other families of the Bunyavirales order
such as the Peribunyaviridae, Nairoviridae, and some members of the Hantaviridae (Ly and Ikegami,
2016). They constitute notoriously difficult targets for structural characterization due to an inherent
tendency to multimerize, as well as the putative presence of substantial intrinsically unfolded
regions. While high-resolution structures of glycoproteins (Dessau and Modis, 2013) and nucleopro-
teins (Ferron et al., 2011; Raymond et al., 2010) from RVFV and several other bunyaviruses have
been determined, no structural information is currently available for any NSs protein, significantly
limiting the current understanding of key bunyaviral virulence mechanisms. Structure and function
can also not be predicted based on sequence, as NSs proteins are ‘ORFans’, with very little
eLife digest Rift Valley fever phlebovirus (RVFV) is a virus of humans and livestock, transmitted
by mosquitos and contact with infected animals. Infection can cause severe disease, including
hemorrhagic fever, and may lead to death. Historically, the virus was only found in central Africa but
it has spread for instance to the Arabian Peninsula. There is a risk that the virus may appear in
temperate regions including Europe because global warming is allowing the mosquitos that carry
the virus to extend their geographic range. There are no vaccines or treatments available for use in
humans so if there is a serious outbreak of the virus it could become an epidemic and cause great
economic losses and severe human disease.
RVFV relies on a protein called NSs to cause disease. In cells of infected animals and humans NSs
forms filaments inside the nucleus, the control center of the cell, and disarms the immune system.
However, it is not known precisely how NSs works.
To address this question, Barski, Brennan et al. used a technique called X-ray crystallography to
study the atomic three-dimensional structure of NSs. This revealed that the center of the protein
contains a core domain that causes the filaments to form. Further experiments identified how the
NSs core comes together to build the filaments inside the cell nucleus.
These findings represent an important step towards understanding how the NSs protein helps
RVFV to cause disease in humans and livestock. In the future, this work may aid the development of
much needed drugs and vaccines against RVFV.
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sequence similarity in members of the Bunyavirales order and the Phlebovirus genus. Despite large
sequence diversity, NSs proteins examined thus far have been found to play roles in the suppression
of the host innate immune response. However, this and the diverse mechanisms of NSs function
have been studied only for a few viruses.
Here we describe the first high-resolution structure of a bunyaviral NSs protein. A truncated sta-
ble, soluble core domain spanning residues 83–248 of RVFV NSs (NSs-DNDC) was identified using
NMR spectroscopy. The corresponding crystal structure represents a novel all-helical fold. Notably,
NSs molecules packed in crystals in double-helical fibrils stabilized by multiple interfaces. Dimensions
of these fibrils are in good agreement with fibrils constituting nuclear NSs filaments in RVFV-infected
cells. Cells infected with recombinant RVFV encoding NSs-DNDC produced nuclear filaments indistin-
guishable from filaments observed in cells infected with parental RVFV. Furthermore, recombinant
viruses encoding full-length NSs with mutations predicted to destabilize significant fibril interfaces,
as suggested by crystal packing, did not induce nuclear filaments. Combination of structural biology
with cell infection assays using reverse genetics to tailor the main RVFV virulence factor identified a
RVFV NSs core domain sufficient for filament formation in vivo, and revealed the structural basis for
NSs nuclear filament formation.
Results
NSs contains a stable central core and a disordered C-terminal tail
Full-length NSs protein (residues 1–265) was expressed as a cleavable MBP fusion yielding only a
small amount (about 0.1 mg per litre of culture) of soluble protein after removal of MBP. Circular
dichroism spectroscopy showed secondary and tertiary structure in mature NSs (Figure 1—figure
supplement 1), however the protein formed large soluble aggregates, eluting in the void volume of
size exclusion chromatography (mass over 200 kDa) (Figure 1A). This construct was therefore rede-
signed in order to obtain a stable, non-aggregating and soluble fragment of NSs. Secondary struc-
ture predictions suggested an N-terminal region with a propensity to form b sheet structure
(residues 1–70), connected by an unstructured linker to a central a-helical domain (85-230). The
C-terminal region was predicted to be natively unfolded (231-265). Deletion of the N-terminal 82
amino acids (resulting in truncated NSs hereafter referred to as NSs-DN, residues 83–265) signifi-
cantly improved expression yields, solubility and stability. In solution, the NSs-DN protein existed in
equilibrium between monomeric and multimeric forms (Figure 1A). Near-UV CD spectra indicated a
helical protein, with characteristic minima at 208 and 220 nm (Figure 1—figure supplement 1).
NSs-DN was highly soluble (up to 30 mg/mL) in near-physiological buffer conditions. A 2D 1H-15N
heteronuclear single-quantum coherence (HSQC) NMR spectrum showed well-dispersed crosspeaks,
indicative of folded, monomeric protein (Figure 1B). The central region of the spectrum, spanning
chemical shifts of 7.5 to 8.5 ppm in the 1H dimension, was dominated by 17 intense and narrow
backbone amide signals, indicating significant flexibility of corresponding residues. Based on sec-
ondary structure and disorder predictions, we concluded the intrinsically unfolded residues were
present at the C-terminus of NSs-DN. Subsequent removal of the C-terminal 17 amino acids (result-
ing in doubly truncated NSs hereafter referred to as NSs-DNDC, residues 83–248) yielded protein
present as a monomer in solution (Figure 1A). Its 1H-15N HSQC spectrum was devoid of all but two
intense crosspeaks observed for NSs-DN (Figure 1B). All other signals overlapped well with cross-
peaks in the NSs-DN spectrum, indicating absence of residues 249–265 does not influence the struc-
ture of NSs-DNDC.
Crystal structure shows the NSs core domain adopts a novel fold
The NSs-DNDC protein was crystallized at conditions optimized following routine sparse-matrix crys-
tallization screens. The crystals were found to be extremely fragile, and diffracted synchrotron X-rays
to 2.2 A˚ resolution. Crystals belonged to space group P6422. Calculation of the Matthews coefficient
indicated a high solvent content of 76%, assuming two molecules in the asymmetric unit. Due to the
absence of any molecular replacement models, experimental phasing had to be undertaken.
Because of the higher-than-average sulfur content of NSs-DNDC (12 sulfurs per chain of 175 resi-
dues) and the highly symmetrical P6422 space group of the crystals, S-SAD phasing was pursued.
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The structure was successfully phased from the anomalous sulfur signal in a single native crystal and
refined to high quality (Table 1).
The NSs-DNDC monomer, molecular mass 19,029 Da, measures approximately 30  30  50 A˚. It
is composed of eight a-helices with helices a1-a6 and a8 arranged around a long central helix a7.
Two short 310 helices are also present (Figure 2). Residues 234–244 are devoid of secondary struc-
ture and traverse approximately 30 A˚ of the NSs surface, packed against helices a3 and a7. Two
Figure 1. (A) Size exclusion chromatography elution traces of recombinantly expressed NSs variants, detected by UV absorption at 280 nm. Elution
volumes for molecular mass markers used for calibration of the column are indicated with dashed lines. (B) 1H-15N HSQC NMR spectra of NSs-DN (blue)
and NSs-DNDC (red) overlaid. The right-hand panel shows the central region of the spectra plotted at high contour levels, selecting a subset of intense
crosspeaks representing highly dynamic amino acid residues, most of which are not present in NSs-DNDC. The dashed line connects crosspeaks of one
side-chain amide.
DOI: https://doi.org/10.7554/eLife.29236.003
The following figure supplement is available for figure 1:
Figure supplement 1. CD spectra of NSs.
DOI: https://doi.org/10.7554/eLife.29236.004
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NSs-DNDC monomers constitute the asymmetric unit, with an interface formed by their a8 helices
(Figure 2—figure supplement 1). There was no visible electron density for the first N-terminal and
the five C-terminal amino acids; these residues are unaccounted for in the crystal structure.
Structural similarity searches with PDBeFold (Krissinel and Henrick, 2004) and DALI (RRID:SCR_
013433) (Holm and Rosenstro¨m, 2010) did not identify significant structural homologues. We there-
fore conclude the NSs-DNDC structure represents a novel fold.
NSs-DNDC in the crystal forms helical fibrils that are stabilized by
extensive interfaces
In the crystal lattice NSs-DNDC molecules were found to pack into a highly organized network of
two fibril-like assemblies, referred to here as F1 and F2 (Figure 3), creating large solvent channels.
Table 1. Data collection and refinement statistics
Data collection
Space group P6422
Cell dimensions a, b, c (A˚)
a, b, g (˚)
123.8, 123.8, 174.0
90, 90, 120
Beamline Diamond i03
Wavelength (A˚) 2.0
Resolution (A˚) 107.83–2.19 (2.25–2.19)
Number of observed reflections 1877448
Number of unique reflections 41684
Completeness (%) 99.9 (99.9)
Rmerge (%) * 9.8 (223.4)
I/d 32.3 (1.6)
Multiplicity 45.0 (18.2)
Anomalous completeness (%) 99.9 (99.8)
Anomalous multiplicity 23.7 (9.4)
Anomalous slope 1.169
Refinement statistics
Rwork (%) † 20.1
Rfree (%) ‡ 21.6
Ramachandran favored (%) 97.24
Ramachandran allowed (%) 99.08
MolProbity score/percentile § 1.61/97
Averaged B-factor (A˚2) 63.47
Rmsd bond length (A˚) 0.905
Rmsd bond angles (˚) 1.007
The values in parenthesis refer to the highest resolution shell.
*Rmerge ¼
P
hkl
P
i
jIðhkl;iÞ ðhklÞ>jP
hkl
P
i
ðhkl;iÞ
where Iðhkl; iÞ is the intensity of an individual measurement of a reflection and ðhklÞ> is
the average intensity of that reflection.
†Rwork ¼
P
hkl
F0 FcP
hkl
F0
where F0 and Fc are the observed and calculated structure factors, respectively.
‡ Rfree is Rwork with 5% of the observed reflections removed before refinement.
§ MolProbity score combines the clashscore, rotamer, and Ramachandran evaluations into a single score, normalized
to be on the same scale as X-ray resolution. 100th percentile is the best among structures of comparable resolution;
0th percentile is the worst. For clashscore the comparative set of structures was selected in 2004, for MolProbity
score in 2006 (Chen et al., 2010).
DOI: https://doi.org/10.7554/eLife.29236.005
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The F1 and F2 crisscross pattern is produced by F1 fibrils running in parallel to each other and the
longest unit cell edge, while F2 fibrils are oriented at an angle of 60˚ with respect to each other, per-
pendicular to F1 (Figure 3—figure supplement 1). F1 and F2 fibrils themselves are best described
as being composed of repeating NSs tetramer units. Four different, partially overlapping (or alterna-
tive) tetramers T1, T2, T3 and T4 can be distinguished that differ in stability and interface areas,
according to PISA interface analyses (Krissinel and Henrick, 2007), with T1 being the most stable
tetramer (Table 2). F1 is an assembly of T1 tetramers stacked at 60˚ angles, while F2 is composed of
alternating T1 and T2 tetramers arranged at 90˚ angles with respect to each other. The T1 interface
that lies parallel to the F1 fibril is largely determined by hydrophobic packing of the a6 helices. The
T1 interface perpendicular to the F1 fibril axis is defined by an extensive network of hydrogen bonds
and salt bridges between the basic face of a1 (Lys84, Gln87, Arg88) and the acidic face of a8
(Glu220, Glu221, Ser228), leading to a large buried interface area of 4  852 A˚2 (Figure 4). The
superficially very similar tetramer T2 in F2 fibrils is less stable. Here the molecules are rotated by
about 8˚ with respect to the orientation of the equivalent monomers in T1, and form a twisted tetra-
mer (Figure 4—figure supplement 1). The register of the a6-a6 interface is shifted, decreasing the
buried surface area by 169 A˚2 compared to the same interface in T1. The total buried surface area is
nearly 1000 A˚2 (17%) smaller in T2 than in T1. The B factors for T2 are also notably higher than for
T1, suggesting that interfaces in T1, and therefore F1, possess a higher degree of conformational
order, contributing to a higher stability of this assembly (Figure 4—figure supplements 1,2). B fac-
tors have been used to distinguish biologically relevant interfaces from crystal packing interfaces,
which have been found to be characterized by relatively high B factors (Liu et al., 2014).
NSs-DNDC T1 tetramers align at 60˚ angles in the F1 fibril, held by a network of hydrogen bonds
clustered around the loop between helices a5-a6 (Figure 4—figure supplement 1). The 60˚ turn
produces a left-handed double helix with twelve monomers per turn and a 34.8 nm pitch (Figure 3).
Figure 2. Structure of RVFV NSs-DNDC. The helical arrangement of NSs shows a novel fold, comprised mainly of eight a-helices. The protein chain is
colored in a rainbow spectrum from the N-terminus to the C-terminus. At the bottom, secondary structure elements are matched with the sequence of
NSs-DNDC (residues 83–248 of NSs). Numbered cylinders represent a-helices; narrower cylinders represent 310 helices. Residues 244–248 are not
defined in the crystal structure.
DOI: https://doi.org/10.7554/eLife.29236.006
The following figure supplement is available for figure 2:
Figure supplement 1. Asymmetric unit formed by two NSs molecules (colors as in Figure 2).
DOI: https://doi.org/10.7554/eLife.29236.007
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Figure 3. Crystal packing of NSs-DNDC. (A) Two fibrillar arrangements, F1 and F2, result from assemblies of alternative tetramers. Two F1 fibrils
(vertical) are shown with alternating shades of red for individual molecules. One F2 fibril (horizontal) is shown with alternating shades of gray for
individual molecules in F2-specific tetramers (T2, T4). F2 fibrils emerge from each F1 tetramer (T1) but for clarity only two F2 (gray) NSs-DNDC molecules
are shown at each node. F2 units are shown in transparent mode on the right hand side F1 fibril to highlight the architecture of F1 fibrils. (B) The F1
fibril is a double helix of NSs-DNDC monomers with 2-fold symmetry around the fibril axis and 6 molecules per 180˚ turn. A section of the F1 fibril
containing five T1 tetramers is shown. One half of the double helix resulting from tetramer stacking is rainbow-colored, the other half is shown in
shades of grey. (C) A simplified representation of a node between F1 and F2 fibrils highlights the architecture of F1 and F2 fibrils and the four different
tetramers T1-T4.
DOI: https://doi.org/10.7554/eLife.29236.008
The following figure supplements are available for figure 3:
Figure supplement 1. Molecular packing in the NSs-DNDC crystal lattice (wall-eye stereo image).
DOI: https://doi.org/10.7554/eLife.29236.009
Figure 3 continued on next page
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The architecture of NSs filaments in cells infected with RVFV
To gain insight into the architecture of nuclear NSs filaments, we infected Vero-E6 cells with the
recombinantly produced parental RVFV strain MP12 as previously described (Billecocq et al., 2008;
Brennan et al., 2014) and imaged cell nuclei containing filaments with transmission electron micros-
copy (TEM). Thick filaments of NSs, 0.5–1 mm in diameter, started forming about four hours post-
infection and averaged to 1–2 filaments per nucleus. TEM reveals a substructure of these filaments
(Figure 5). They appear to be composed of a bundle of tightly packed, extended parallel fibrils with
diameters roughly ranging from 8 to 15 nm.
Recombinant RVFV expressing NSs-DNDC forms filaments in live cell
nuclei
Recombinant RVFV encoding NSs-DNDC (rMP12NSsDNDC) was rescued. Working stock of recombi-
nant virus achieved similar titers (1.15  108 pfu/mL) to parental MP12 (2.00  108 pfu/mL) and no
difference in plaque morphology was observed. Reverse transcription PCR analysis was performed
to confirm the presence of the NSs truncation. Vero-E6 cells were infected with the recombinant
rMP12NSsDNDC strain. Twenty-four hours after infection NSs-specific immunofluorescence staining
showed prominent filaments in nuclei of infected cells (Figure 6). The morphology of these NSs-D
NDC filaments was indistinguishable from structures observed for the parental MP12 strain encoding
full-length NSs. Fibrillation was observed only in about 30% of cells infected with rMP12NSsDNDC,
compared to occurrence of filaments in nearly all cells infected with parental virus.
Engineering of interfaces observed in NSs-DNDC crystals prevents NSs
filament formation in infected cells
To test if the fibrillar crystal packing observed for NSs-DNDC represents a biologically relevant
assembly underpinning intranuclear NSs filament formation, combinations of two key residues in
three different crystal interfaces were mutated (Figure 4). Residues were chosen that were predicted
to be critical for assembly of tetramers present in both or either F1 and F2 fibrils, but not essential
for monomer stability. Three NSs variants were generated: NSs-DNDC-muT1 (Arg88Asp, Ser228Ala),
NSs-DNDC-muT3 (Lys150Gly, Thr152Gly) and NSs-DNDC-muT4 (Ile216Asp, Met219Ala). Disruption
of the polar T1 interface, perpendicular to F1, would interrupt both T1 and T2, and therefore F1 and
F2. Residue Arg88, forming two salt bridges to Glu220 and Glu221, was mutated to an aspartate.
Ser228, forming a side-chain hydrogen bond with Gln87, was replaced by alanine. The T3 interface,
unique to F1, was targeted through replacement of Lys150 and Thr152 with glycines. The hydropho-
bic T4 interface, formed by the a8 helices of the two molecules in the asymmetric unit of the crystals,
Figure 3 continued
Figure supplement 2. Model of a full-length NSs fibril with the NSs-DNDC F1 assembly as core (shown in surface representation).
DOI: https://doi.org/10.7554/eLife.29236.010
Figure supplement 3. Accessibility of the a8 helix (red) in F1 and F2 fibrillar crystal assemblies.
DOI: https://doi.org/10.7554/eLife.29236.011
Table 2. Summary of PISA analyses of buried surface areas and DG values of the four unique NSs-D
NDC tetramers present in the crystal lattice. DGsol and DGdiss are free energy of solvation (negative
values indicate favorable process), and free energy of dissociation of assembly (positive values
indicate stable association), respectively.
Buried surface [A˚2] DGsol [kcal/mol] DGdiss [kcal/mol]
T1 5631  33.1 10.6
T2 4654  26.4 1.6
T3 4358  25.2  3.0
T4 4892  23.9 2.6
DOI: https://doi.org/10.7554/eLife.29236.015
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is unique to F2; it was changed by mutating Ile216 to aspartate and Met219 to alanine. These two
residues contribute about 50% of the total buried surface area to the a8-a8 interface.
NMR spectroscopy was used to assess the effect of these mutations on the folded state of NSs-D
NDC in solution. 1H spectra agreed with conservation of structure in all mutated proteins (Figure 7—
figure supplement 1). All spectra showed the same signal dispersion and no indications of signifi-
cant changes in structure, such as partial unfolding. High-field shifted methyl signals between  1
and 0 ppm were observed at the same chemical shifts in all spectra. Such signals belong to buried
aliphatic side-chains, and conservation of their chemical shifts reflects preservation of the hydropho-
bic packing in the protein variants.
Three recombinant viruses encoding full-length NSs containing interface mutations were rescued,
rMP12muT1NSs, rMP12muT3NSs, and rMP12muT4NSs. Recombinant viruses grew to similar titers
Figure 4. Interaction interfaces within the F1 and F2 fibrils observed in the NSs-DNDC crystal. In the overview of an F1/F2 node (top right) key interface
residues targeted by mutagenesis are shown as cyan, yellow and lime spheres for interfaces in T1, T3 and T4, respectively. Expanded regions highlight
the residues involved in the three different interfaces. H-bond networks and salt bridges (dashed black lines) stabilize the interfaces for T3 and T1. The
a8-a8 interface in T4 is defined by hydrophobic interactions. Residues changed by mutagenesis are marked by asterisks.
DOI: https://doi.org/10.7554/eLife.29236.012
The following figure supplements are available for figure 4:
Figure supplement 1. Comparison of T1 and T2 tetramers.
DOI: https://doi.org/10.7554/eLife.29236.013
Figure supplement 2. B-factor distribution in the NSs fibrillar crystal assembly.
DOI: https://doi.org/10.7554/eLife.29236.014
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to that of the parental virus rMP12 and had indistinguishable plaque morphologies. Segment specific
RT-PCR followed by Sanger sequencing was used to confirm the genomic composition of recombi-
nant viruses. NSs-specific immunofluorescence staining showed the presence of filaments in nuclei of
rMP12mut4NSs infected Vero-E6 cells (Figure 7). In contrast, no filaments were observed in nuclei
of cells infected with rMP12muT1NSs and rMP12muT3NSs. In both cases NSs was detected as
speckles or diffusely dispersed throughout the nuclei (Figure 7). These data indicate that all three
NSs variants had retained the ability to be imported into nuclei. Mutating interfaces observed in the
F1 crystal fibril clearly affected intranuclear NSs filament formation, whereas mutating an interface
unique to the F2 fibril did not. Therefore, we conclude that the F1 crystal fibril is not only more sta-
ble than F2, but that it also represents the architecture of NSs in intranuclear filaments.
Discussion
Innate immune antagonism is a common function of many viral non-structural proteins (Randall and
Goodbourn, 2008), including NSs proteins from bunyaviruses (Walter and Barr, 2011). Non-struc-
tural viral proteins have been previously structurally characterized, such as the NS1 protein of influ-
enza virus (Bornholdt and Prasad, 2008; Liu et al., 1997), VP35 of Ebola virus (Leung et al., 2009)
or NS5A from hepatitis C virus (Feuerstein et al., 2012; Tellinghuisen et al., 2005). These studies
have contributed to understanding both viral pathology and the innate immune system.
The NSs protein is the main virulence factor of RVFV and most bunyaviruses. RVFV lacking NSs
cannot inhibit the interferon response and causes asymptomatic infection in mice (Bouloy et al.,
2001; Muller et al., 1995; Vialat et al., 2000). Naturally occurring RVFV clone 13 encoding NSs
lacking residues 16–198 (Muller et al., 1995), and a recombinant virus deficient of NSs, are currently
candidates for live-attenuated vaccines for RVFV (Bird et al., 2008; Bird et al., 2011). The mode of
action of RVFV NSs is understood to an extent. Several binding partners have been identified, and
models for NSs function proposed (Ly and Ikegami, 2016). The underlying mechanisms of these
Figure 5. TEM observations of fibrils formed in the nuclei of cells infected with RVFV. The outline of an NSs filament within a cell nucleus is indicated in
the left panel by red arrowheads. Higher magnifications (middle and right panels) reveal a substructure of NSs filaments, which are composed of
bundles of parallel fibrils with estimated widths of 8–15 nm. Cyan arrowheads in the right panel indicate one fibril with a width of 10 nm.
DOI: https://doi.org/10.7554/eLife.29236.016
Barski et al. eLife 2017;6:e29236. DOI: https://doi.org/10.7554/eLife.29236 10 of 20
Research article Biophysics and Structural Biology Microbiology and Infectious Disease
interactions are however unknown, arguably because so far NSs proteins have largely evaded molec-
ular and structural characterization. Here we report the first structure of a bunyaviral NSs protein.
Recombinant full-length RVFV NSs was found to form large aggregates in solution, and was not
suitable for NMR or crystallography. Therefore, we designed a stable construct amenable to crystalli-
zation through double deletion of 82 N-terminal and 17 C-terminal residues (NSs-DNDC). Both these
regions had previously been linked to biological functions of NSs, particularly its intranuclear locali-
zation and fibrillation (Yadani et al., 1999; Billecocq et al., 2004; Cyr et al., 2015). However, we
demonstrate that a recombinant virus containing NSs-DNDC successfully induces filament assembly
in nuclei of infected cells (Figure 6), indicating neither the truncated N- or C-terminal regions are
required for fibrillation.
NSs does not contain any nuclear localization signals, thus nuclear import likely relies on host pro-
teins such as the p44 subunit of the TFIIH transcription complex (Le May et al., 2004). Interaction
sites for any such binding partners are predicted to be near the N-terminus, since mutation of a
PxxP putative protein interaction motif (residues 29–32) results in retention of NSs in the cytoplasm
(Billecocq et al., 2004). Our data, however, show that the N-terminal 82 residues of NSs (including
the 29–32 motif) are dispensable for nuclear localization.
Deletion of 17 C-terminal residues was based on 2D NMR of NSs-DN showing the presence of an
intrinsically unfolded region. Notably, this truncation matches one reported in a study where RVFV
NSs lacking these C-terminal residues (encoded by recombinant Semliki Forest virus) was localized in
nuclei of infected cells, but did not form filaments (Yadani et al., 1999). A more recent study
Figure 6. Intracellular localization of NSs in rMP12- or rMP12NSs-DNDC-infected Vero-E6 cells. Cells were fixed 24
h p.i. and co-stained with either anti-N or anti-NSs antibodies (green) as indicated and DAPI (blue).
DOI: https://doi.org/10.7554/eLife.29236.017
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suggests the 261-FVEV-264 motif is the binding site for the TFIIH subunit p62, and this interaction is
required for filament formation (Cyr et al., 2015). While the C-terminal tail (including the FVEV
motif) is missing in the NSs-DNDC construct, we nevertheless observed intranuclear filaments indis-
tinguishable from filaments in rMP12-infected cells. Therefore, neither the intrinsically disordered
C-terminal nor the N-terminal regions of NSs are required for filament formation.
The discrepancies between published results and our findings regarding the terminal regions of
NSs may be reconciled if a role for the N-terminal domain of NSs in self-association is considered.
The N-terminal domain is included in the NSs constructs used in both studies cited above
(Cyr et al., 2015; Yadani et al., 1999) that suggest a critical role of the C-terminal tail for NSs self-
association. However, removal of the N-terminal domain had a clear effect on the oligomeric state
of NSs-DN, where the C-terminal tail is present (Figure 1A). In crystal fibrils, NSs-DNDC N- and
C-termini are close to an apparent cleft in the middle of tetramer T1, which could accommodate the
N-terminal domain, assuming full-length NSs fibrils contain the same core-domain arrangement. In
which case, intermolecular interactions between monomer terminal regions are likely (Figure 3—fig-
ure supplement 2). Arguably, deletion of either N- or C-terminal regions results in non-native inter-
actions that destabilize fibrils, artifacts abrogated in a doubly truncated construct.
Our data have implications for understanding the interaction between NSs and TFIIH. The model
for NSs function previously proposed (Cyr et al., 2015) assumes initial binding of NSs to p62, with
subsequent disintegration of the TFIIH complex, followed by sequestration of p44 into NSs filaments
(Le May et al., 2004). This hypothesis is not supported by our findings, as NSs-DNDC lacks the puta-
tive p62-binding motif and still yields filaments. The apparent similarity in size and shape of NSs-D
NDC filaments to full-length NSs does not allow conclusions about their composition. We cannot
rule out the possibility that NSs-DNDC filaments observed in vivo are lacking other proteins such as
p44 possibly associated with full-length NSs filaments.
The NSs core domain structure reported here represents a novel fold. Comparison of the second-
ary structure distribution in NSs-DNDC and secondary structure predictions for other phleboviral NSs
proteins shows very good agreement, suggesting that, despite low to moderate sequence identity
Figure 7. Intracellular localization of NSs in Vero-E6 cells infected with rMP12 or rMP12 variants encoding NSs variants with interface residue mutations
(muT1, muT3, muT4). Cells were fixed 24 h p.i. and co-stained with either anti-N or anti-NSs antibodies (green) as indicated and DAPI (blue).
DOI: https://doi.org/10.7554/eLife.29236.018
The following figure supplement is available for figure 7:
Figure supplement 1. 1D 1 hr NMR spectra of NSs-DNDC and interface mutation variants.
DOI: https://doi.org/10.7554/eLife.29236.019
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Figure 8. Sequence alignment of NSs proteins from human-pathogenic phleboviruses (SFTS, severe fever with thrombocytopenia syndrome virus).
Secondary structure elements for RVFV-NSs are shown on top of the alignment panels. For the N-terminal domain (top panel) these are based on
Figure 8 continued on next page
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of this core region (15–32%), all phleboviral NSs proteins share a similar core domain fold (Figure 8).
They do however vary greatly in their N- and C-terminal regions, which is particularly evident when
comparing NSs from viruses transmitted by mosquitos and sandflies (e.g. RVFV, sandfly fever viruses)
with viruses transmitted by ticks (e.g. Heartland phlebovirus and SFTS phlebovirus) (Figure 8).
The finding of highly organized fibrils in the NSs-DNDC crystal lattice is intriguing due to the natu-
ral propensity of NSs for fibrillation in nuclei of RVFV-infected cells. Mutagenic analyses of interfaces
defining the two types of crystal fibrils suggested that F1 likely represents the core architecture of
NSs filaments, while F2 is a crystal packing artifact. T1 and T3 interface NSs variants were both
detected in nuclei of infected cells. In immunofluorescence staining the muT3 interface variant
appeared to be much more abundant than the muT1 variant, suggesting that the muT3 variant of
NSs may be more stable than the muT1 interface mutant. This agrees with the predicted stability of
the T1 tetramer (Table 2), making it less prone to degradation. To our knowledge, no other Phlebo-
virus causes intranuclear filament formation, and none of the residues stabilizing interfaces among
NSs-DNDC crystal fibrils is conserved in NSs sequences of phleboviruses other than RVFV.
Biological relevance of the F1 fibril is also supported by accessibility of the a8 helix in this assem-
bly (Figure 3—figure supplement 3), which is partially buried in the F2-specific T1-T2 interface (Fig-
ure 4). This helix harbors a binding site for SAP30, a component of a repressor complex that
regulates transcription of the interferon-b promoter (Le May et al., 2008). NSs arranged in the man-
ner observed in NSs-DNDC crystals would be able to bind to SAP30 and modulate SAP30 function.
PISA interface analysis indicates that potentially some NSs-DNDC oligomers, but neither F1 nor
F2 fibrils would be stable in solution. This agrees with the observation that NSs is distributed
throughout the cytoplasm at early time points in cell infection experiments, and only forms distinct
filaments inside nuclei. Fibrillation therefore depends on factors present in the nucleus, but not the
cytosol. Essential factors could be binding partners, but also other conditions that shift the associa-
tion equilibrium of NSs towards fibrils such as the excluded volume effect, or molecular crowding,
which plays a role in compartmentalization and architecture of cell nuclei (Hancock, 2004;
Richter et al., 2008). It is tempting to speculate that intranuclear crowding conditions are mimicked
in crystallization where an excluded volume effect is induced by the precipitant polyethylene glycol
(PEG).
RVFV is one of the most dangerous human pathogens with the potential to cause wide epidemics
in the near future. The first high-resolution structure for the main RVFV virulence factor NSs and
other data presented here will facilitate a deeper understanding of NSs function. Ongoing research
will help determine if NSs filament assembly is required for virulence, a question that this study does
not attempt to answer. NSs proteins of phleboviruses and other members of the Bunyavirales order
are highly diverse in sequence, but all play roles in suppressing the innate immune response through
various mechanisms (Ly and Ikegami, 2016). In infected cells, NSs proteins are located in the nuclei
and cytosol, or the cytosol only. Currently no other NSs protein is known to cause filaments charac-
teristic for RVFV. To establish whether this unique property of RVFV NSs is related to virulence may
require animal models, since NSs is dispensable for viral replication and in vitro cell infection, but is
required to cause pathology (Bouloy et al., 2001). The structure-based insights presented here
should facilitate such studies. Development of modulators of fibril formation may be an attractive
option for new therapeutics, especially given the conservation of interface residues in RVFV isolates.
Materials and methods
Protein expression and purification
Expression constructs were prepared by cloning RVFV strain MP12 cDNA comprising full-length (res-
idues 1–265), DN (residues 83–265), and DNDC (residues 83–248) regions of NSs into a modified
Figure 8 continued
secondary structure prediction by JPred4 (Drozdetskiy et al., 2015) (dashed lines). Sequence similarity is indicated by gray shading for residues
conserved or similar in at least 80% of sequences. Regions displayed in gray font are not aligned. Secondary structure predictions are also shown below
each panel for Toscana virus and SFTS virus NSs.
DOI: https://doi.org/10.7554/eLife.29236.020
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pMal-C2x vector (New England Biolabs, MA, USA) containing an N-terminal hexahistidine tag down-
stream of the malE (MBP) gene and a tobacco etch virus (TEV) protease sequence. Proteins were
expressed using Escherichia coli BL21 (DE3). Cells were grown at 37˚C in Luria-Bertani broth to an
OD600 of 0.6. Protein expression was induced with a final concentration of 0.5 mM isopropyl b-d-1-
thiogalactopyranoside and allowed to proceed overnight at 18˚C. Cells were pelleted by centrifuga-
tion and lysed in the presence of 10 mM phosphate buffer, 300 mM NaCl, 20 mM imidazole, pH 7.2
using sonication. Soluble proteins were separated from cell debris by centrifugation. Soluble protein
was purified by nickel metal-affinity chromatography (IMAC). After binding, resin was washed exten-
sively with 10 mM phosphate buffer, 2 M NaCl, 20 mM imidazole, pH 7.2 in order to dissociate any
bound DNA. MBP-NSs was eluted in 10 mM phosphate buffer, 300 mM NaCl, 250 mM imidazole,
pH 7.2, and dialyzed overnight at 4˚C in 10 mM phosphate buffer, 300 mM NaCl, 2 mM DTT, pH 7.2
with simultaneous cleavage by TEV protease. MBP was separated from NSs by reverse nickel IMAC.
NSs was further purified by size exclusion chromatography on a 16/60 S75 Superdex column (GE
Healthcare, UK) in 10 mM phosphate, 300 mM NaCl, 1 mM DTT, pH 7.2.
Interface mutation variants of NSs-DNDC were generated through site-directed mutagenesis.
NSs-DNDC-muT1 (Arg88Asp, Ser228Ala) was generated in two stages of amplification, while NSs-D
NDC-muT3 (Lys150Gly, Thr152Gly) and NSs-DNDC-muT4 (Ile216Asp, Met219Ala) were made in sin-
gle steps. Interface mutation variants were expressed and purified as previously described for wild-
type NSs-DNDC.
Crystallization and structure determination
NSs 83–248 (NSs-DNDC) was dialyzed into 20 mM HEPES, 150 mM NaCl, 1 mM DTT, pH 7.2, con-
centrated to 30 mg mL 1. Protein crystals were grown at 4˚C by sitting-drop vapor diffusion in 0.1 M
Tris-HCl pH 8.5, 8% (w/v) PEG 10,000 with protein and reservoir combined in a 2:1 ratio. Crystals of
NSs-DNDC grew as elongated hexagons and reached their maximum size of about 0.3  0.1  0.1
mm after two weeks. Crystals were cryo-protected by brief immersion in reservoir supplemented
with 30% (v/v) glycerol then flash frozen in liquid nitrogen. Native and anomalous data were col-
lected using a 2.0 A˚ wavelength beam at the Diamond Light Source (I03 beamline). Diffraction over
a 500˚ angle yielded a high-multiplicity dataset with maximum resolution of 2.2 A˚. Crystals indexed
in space group P6422 with cell dimensions a = 123.8 A˚, b = 123.8 A˚, c = 174 A˚; a = 90˚, b = 90˚,
g = 120˚. Data were indexed and integrated using XDS, scaled using XSCALE (Kabsch, 2010), and
merged with Scala (Evans, 2006). The structure was solved by single anomalous dispersion (SAD);
phase determination from native sulfur anomalous signal was performed using SHELX (Shel-
drick, 2010). PHENIX (RRID:SCR_014224) AutoBuild was used for initial automated model-building
(Terwilliger et al., 2008). Density modification and model refinement was performed with
REFMAC5 (RRID:SCR_014225) (Murshudov et al., 1997) and Coot (RRID:SCR_014222)
(Emsley et al., 2010). Structure validation was conducted with the MolProbity (RRID:SCR_014226)
server (Chen et al., 2010). Data collection and refinement statistics are listed in Table 1.
NMR spectroscopy
NSs constructs were isotopically labeled by expression in M9 minimal media, supplemented with 1 g
L 1 of 15NH4Cl and purified as described above for native proteins. NMR samples typically contained
0.3 mM protein in 10 mM phosphate, 50 mM NaCl, 0.25 mM DTT, pH 7.2, 5% (v/v) D2O.
1H-15N
HSQC spectra were recorded on a Bruker DRX500 spectrometer equipped with a 5 mm TXIz probe
at 15˚C. Spectra were processed with NMRPipe (Delaglio et al., 1995) and analyzed with CCPN
Analysis 2 (Vranken et al., 2005). For interface mutation variants of NSs-DNDC, samples contained
0.03–0.25 mM protein in 10 mM phosphate, 150 mM NaF, 1 mM DTT, pH 7.2, 5% (v/v) D2O. One-
dimensional 1H spectra were recorded with a spectral resolution of 1.7 Hz on a Bruker Ascend 700
MHz spectrometer equipped with a Prodigy TCI probe at 22˚C. The spectra were processed and
analyzed using Bruker Topspin 3 (RRID:SCR_014227).
Cells and viruses
Vero-E6 cells (RRID:CVCL_0574) were purchased from the European Collection of Authenticated
Cell Cultures (ECACC), and tested negative for mycoplasma. Cells were grown in Dulbecco’s modi-
fied Eagle’s medium (DMEM) supplemented with 10% (v/v) fetal calf serum. Cell lines were grown at
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37˚C with 5% CO2 unless otherwise stated. Recombinant viruses containing truncated or mutated
NSs proteins were generated using reverse genetics as previously described (Brennan et al., 2014;
Le May et al., 2008). Stocks of recombinant viruses were grown in BHK-21 cells at 33˚C by infecting
at a multiplicity of infection (MOI) of 0.01 and harvesting the culture medium at 5–7 days post infec-
tion (p.i.) All experiments with infectious virus were conducted under containment level 3 conditions.
RT-PCR analysis of p1 stock viruses was performed to confirm the correct configuration of the
recombinant virus S RNA.
Virus titration by plaque assay
BHK-21 (clone 13) cells (RRID:CVCL_1915) were purchased from the European Collection of Authen-
ticated Cell Cultures (ECACC), and tested negative for mycoplasma. Cells were infected with serial
dilutions of virus and incubated under an overlay consisting of Glasgow minimum essential medium
(GMEM) supplemented with 2% (v/v) newborn calf serum and 0.6% Avicel (w/v) (FMC
BioPolymer, Philadelphia, PA) at 37˚C for 4 days. Cell monolayers were fixed with 4% (w/v) formalde-
hyde and plaques were visualized by Giemsa staining.
Immunofluorescence microscopy of infected cells
Vero-E6 cells were grown on glass coverslips (13 mm diameter), infected with recombinant or paren-
tal RVFV at an MOI of 5 and fixed at 24 h p.i. in 4% (w/v) formaldehyde in PBS. After permeabiliza-
tion with 0.1% (v/v) Triton X-100 in PBS, cells were stained with specific primary antibodies, followed
by secondary antibody conjugates. Localization of the fluorescently labeled proteins was examined
using a Zeiss LSM-710 confocal microscope. Images in Figures 6 and 7 are representatives of two
independent infection experiments, with two repeats for each antibody.
Thin-section electron microscopy
Monolayer cultures of Vero-E6 cells were seeded in 6-well plates and infected with RVFV MP12 for
24 h p.i. at an MOI of 3, and subsequently fixed with 2.5% (v/v) glutaraldehyde overnight at 4˚C.
Cells were scraped and pelleted by centrifugation followed by fixation with 1% (w/v) osmium tetrox-
ide (TAAB Labs, UK) and staining with 2% (w/v) aqueous uranyl acetate for 1 hr at room tempera-
ture. Cells were then harvested into PBS and pelleted through 1% (w/v) SeaPlaque agarose
(Sigma, UK) at 45˚C. The agar was set at 4˚C and cell pellets were cut into ~1 mm cubes, which were
dehydrated through a graded alcohol series (30–100% (v/v)) and embedded in Epon 812 resin
(TAAB Labs, UK) followed by polymerization for 3 days at 65˚C. Thin sections of 120 nm were cut
with a UC6 ultramicrotome (Leica Microsystems, Germany) and examined with a JEOL 1200 EX II
electron microscope and images were recorded on a Gatan Orius CCD camera.
Accession code
The NSs-DNDC protein structure, and the data used to derive these, have been deposited at PDBe
(RRID:SCR_004312) with accession number 5OOO.
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